StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.95+0.05 (+5.37%)

Close on Nov 17, 2026Market cap $622.03KP/E –Yield –

Earnings

Decoy Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2023
–
EPS, Q2 FY2023
-$1.43
-$0.09 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Decoy Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2025ended Jun 30, 2025Jul 31, 2025after the close–––Filing
Q4 FY2024ended Dec 31, 2024Jan 17, 2025after the close–––Filing
Q2 FY2023ended Jun 30, 2023Aug 10, 2023after the close––-$1.43Release
Q3 FY2022ended Sep 30, 2022Nov 10, 2022before the open––-$6.41Release
Q2 FY2022ended Jun 30, 2022Aug 15, 2022after the close––-$0.09Release
Q1 FY2022ended Mar 31, 2022May 12, 2022after the close––-$0.13Release
Q4 FY2021ended Dec 31, 2021Mar 10, 2022after the close––-$0.09Release
Q2 FY2021ended Jun 30, 2021Aug 5, 2021after the close–––Filing
Q1 FY2021ended Mar 31, 2021May 12, 2021after the close–––Filing
Q3 FY2020ended Sep 30, 2020Nov 12, 2020before the open–––Filing
Q2 FY2020ended Jun 30, 2020Jul 29, 2020after the close–––Filing
Q1 FY2020ended Mar 31, 2020May 14, 2020after the close–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Decoy Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Decoy Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Decoy Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Update
  4. Update
  5. News
  6. News
  7. News
  8. Update
  9. News
  10. News
  11. News
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?